CEO Spotlight: Kylee Hall
Interview with Kylee Hall, chief executive of medical device maker Cylite, on joining the Main Sequence-backed company, scaling its team, and preparing a deep-tech healthcare business for a future sale.
Company
Every investor coverage indicates participated in a round Cambridge raised.
Companies Cambridge acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Cambridge. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Interview with Kylee Hall, chief executive of medical device maker Cylite, on joining the Main Sequence-backed company, scaling its team, and preparing a deep-tech healthcare business for a future sale.
Tenacious Ventures introduces Dr. Madeline Mitchell, an agricultural scientist previously at Breakthrough Victoria and Food Agility, as its new investment principal, discussing deep tech, agrifood innovation and climate science.
Sydney neurotech firm Omniscient has banked a Series C from Gina Rinehart and Will Vicars, funding a push into the United States for its connectomics platform.